Ataxie cérébelleuse subaiguë : une atteinte atypique par le SARS-CoV-2 chez la personne âgée [Subacute cerebellar ataxia, an uncommon SARS-CoV-2 complication infection in older adults]

Details

Ressource 1Download: file.pdf (146.85 [Ko])
Under embargo until 02/05/2024.
UNIL restricted access
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_5D1A0AA3A243
Type
Article: article from journal or magazin.
Publication sub-type
Case report (case report): feedback on an observation with a short commentary.
Collection
Publications
Institution
Title
Ataxie cérébelleuse subaiguë : une atteinte atypique par le SARS-CoV-2 chez la personne âgée [Subacute cerebellar ataxia, an uncommon SARS-CoV-2 complication infection in older adults]
Journal
Revue medicale suisse
Author(s)
Perret T., Major K., Bosshard W., Büla C., Rouaud O.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
02/11/2022
Peer-reviewed
Oui
Volume
18
Number
802
Pages
2053-2056
Language
french
Notes
Publication types: Case Reports ; English Abstract ; Journal Article
Publication Status: ppublish
Abstract
Cerebellar ataxia can be caused by neoplasia, toxics (drugs, heavy metals, alcohol), infection, vascular lesions or auto-immune and paraneoplastic pathologies. Neuroimaging must be performed urgently in case of sudden onset and serologies as well as a lumbar puncture should be performed. Several case reports of ataxia associated with COVID-19 have been published, however the underlying pathogenic mechanisms remain unclear. This is a diagnosis of exclusion when other causes are ruled out and when the ataxia appears simultaneously to COVID-19 infection. We lack data on best management, but the prognosis appears mostly favorable with good functional recovery without any specific treatment. This paper describes the case of a patient who developed a cerebellar ataxia as the only neurological manifestation of a SARS-CoV-2 infection.
Keywords
Humans, Aged, Cerebellar Ataxia/etiology, Cerebellar Ataxia/complications, COVID-19/complications, SARS-CoV-2, Magnetic Resonance Imaging, Autoantibodies
Pubmed
Create date
23/11/2022 10:31
Last modification date
04/10/2023 7:11
Usage data